Philippe Laplaige
Blois, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Bevacizumab-based chemotherapy adaptive to pharmacokinetic of bevacizumab in first-line treatment of patients with unresectable metastatic colorectal cancer: A double-blind, multicenter, randomized phase III trial study (PHARBEVACOL trial).
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: February 09, 2025
Febrile neutropenia prophylaxis, G-CSF physician preferences: discrete-choice experiment.
Journal: BMJ supportive & palliative care
Published: May 10, 2021
Hot-clot artifact in the lung parenchyma on 18F-fluorodeoxyglucose positron emission tomography/computed tomography mimicking malignancy with a homolateral non-small cell lung cancer.
Journal: World journal of nuclear medicine
Published: June 02, 2020
Efficacy and Safety of Bevacizumab Combined With First-Line Chemotherapy in Elderly (≥75 Years) Patients With Metastatic Colorectal Cancer: A Real-World Study.
Journal: Clinical colorectal cancer
Published: June 26, 2019
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 28, 2015
A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000).
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 22, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026